New AI Collaboration: Expanding Drug Discovery with Variational AI's Enki™ Platform

Preview text: New AI Collaboration: Expanding Drug Discovery with Variational AI's Enki™ Platform View…

Sunday, Aug 2, 2026 at 4:01 PM EasternMailchimp

Rakovina TherapeuticsNew AI Collaboration: Expanding Drug Discovery with Variational AI's Enki™ Platform

Image not available

No image available for this email.

Subject: New AI Collaboration: Expanding Drug Discovery with Variational AI's Enki™ Platform
Preview text: New AI Collaboration: Expanding Drug Discovery with Variational AI's Enki™ Platform View…
From: services@staccc.com
Brand: Rakovina Therapeutics
ESP: Mailchimp
Sent: Sun Aug 2, 2026, 4:01 PM ET
Size: 42 KB
Images: 10
Links: 12, 3 of them buttons
Subject length: 83 characters

Against Rakovina Therapeutics's usual

Sent in its busiest hour, 4 PM, which holds 31% of its emails. The subject is 83 characters; its average is 70.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Rakovina <[email protected]>
Reply-To: Rakovina <[email protected]>
Subject: New AI Collaboration: Expanding Drug Discovery with Variational AI's Enki™ Platform
Date: Sun, 2 Aug 2026 20:01:18 +0000
Message-ID domain: mail201.suw12.mcsv.net
Return-Path domain: mail201.suw12.mcsv.net
DKIM signature: d=mailchimpapp.net s=k3
List-Unsubscribe: Present, one-click
Mailer: Mailchimp Mailer
Feedback-ID sender: mc

Other sending headers (names only): X-Campaign, X-campaignid, X-Report-Abuse, X-MC-User, X-Accounttype

	Aug 31, 2026 7:00 PM	Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
	Aug 31, 2026 4:42 PM	Rakovina Therapeutics Announces Final Closing of Upsized Non-Brokered Private Placement
	Aug 19, 2026 7:01 AM	Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
	Aug 12, 2026 4:30 AM	Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement
	Aug 2, 2026 4:01 PM	New AI Collaboration: Expanding Drug Discovery with Variational AI's Enki™ Platform (this email)
	Jul 29, 2026 3:59 PM	How AI is Revolutionizing DDR-Based Cancer Therapies at Rakovina Therapeutics
	Jul 26, 2026 3:57 PM	Thank You for Signing Up!